Neptune Technologies Bioresour (NASDAQ:NEPT)

CAPS Rating: 1 out of 5

The Company develops proprietary and potent health ingredients from underexploited marine biomasses, such as krill, with its patented extraction process.

Results 1 - 20 of 20

Recs

0
Member Avatar bIlluminati (30.49) Submitted: 10/14/2014 12:10:28 PM : Underperform Start Price: $1.18 NEPT Score: -51.86

Around the drain.

Recs

0
Member Avatar pchop123 (80.39) Submitted: 7/31/2014 4:42:14 PM : Underperform Start Price: $2.13 NEPT Score: +18.22

good short

Recs

0
Member Avatar jed71 (88.61) Submitted: 12/3/2013 1:56:27 PM : Underperform Start Price: $2.54 NEPT Score: +40.55

Here is the Diluted Weighted Average Shares increases over the past 5 years:

2009 37,623 diluted shares
2010 37,913
2011 40,464
2012 48,205
2013 54,071
Current 60,600

So at the current pace, they will have easily doubled their shares by the end of 2014. The only thing this company is good at is issuing new shares to the detriment of current shareholders. And if you can, take a look at the quarterly declines in their revenues. This is not going to end well for existing shareholders.

Recs

0
Member Avatar SHBecker (< 20) Submitted: 11/21/2013 7:48:53 AM : Outperform Start Price: $2.46 NEPT Score: -38.35

Company is rebuilding capacity in Krill area; has patent litigation which if successful will permit it to own North American market for Krill and has as an additional upside stakes in subsidiaries that are developing Krill medical food and pharmaceuticals.

Recs

1
Member Avatar Allstar13913 (99.84) Submitted: 7/22/2011 5:07:24 PM : Underperform Start Price: $4.33 NEPT Score: +111.30

Krill Oil? This is crap.

Recs

1
Member Avatar BuffettJunior1 (97.71) Submitted: 6/22/2011 5:04:38 PM : Underperform Start Price: $3.50 NEPT Score: +108.39

Trash stock.

Recs

0
Member Avatar walhersh (97.30) Submitted: 6/16/2011 11:17:52 AM : Underperform Start Price: $3.57 NEPT Score: +108.75

spam

Recs

4
Member Avatar TMFStockSpam (99.99) Submitted: 6/15/2011 4:47:07 PM : Underperform Start Price: $3.64 NEPT Score: +110.65

Dear Mr. Smith,
With the SEC taking important steps last week to suspend trading of 17 fraudulent penny stocks, much needed action was taken against microcap fraud and certain groups that work with them. An important step in helping investors to make informed choices when it comes to the potentially lucrative, yet volatile nature of penny stocks, believes investment analyst Peter Leeds.
While penny stocks certainly aren’t for everyone, penny stocks can be a valuable part of an investor’s portfolio. Below, Leeds provides his list of the top 5 penny stocks to own this summer, noting all of these companies are fundamentally solid, with great upside. Leeds is available for interview to further discuss these penny stock picks.

Neptune Technologies & Bioresources, Inc.
NEPT (Nasdaq)
Health conscious people often become even more so in the summer. Whether training for the olympics, or just trying to be generally healthy, Neptune can help.
A recognized leader of science based products for the nutraceutical and pharmaceutical markets, Neptune Technologies & Bioresources, Inc. (NEPT) is a profitable company with strong fundamentals, growing revenues, and great momentum.

Recs

0
Member Avatar urbanmullen (< 20) Submitted: 6/14/2011 10:34:30 PM : Outperform Start Price: $3.60 NEPT Score: -108.53

new product for world wide market

Recs

0
Member Avatar cashyash (84.11) Submitted: 4/27/2011 12:33:21 AM : Outperform Start Price: $3.47 NEPT Score: -98.41

This is best in class in a $30 Billion hyperlipidemia drug industry.

Recs

0
Member Avatar KittyLitterClump (62.76) Submitted: 4/26/2011 2:24:40 PM : Outperform Start Price: $3.53 NEPT Score: -99.63

Already making money and more items in the pipeline with little or no side effects. I like this over several years. It's probably hit a ceiling now (3.50), but long term I like it's potential.

Recs

0
Member Avatar MarginCallMcW (21.59) Submitted: 4/25/2011 3:51:37 PM : Outperform Start Price: $3.67 NEPT Score: -103.08

Lots of negativity in the CAPS community on this one, but I will take the other side. I have done well on this in real life and think it still has some room to grow (with obvious risks).
Good bull case here: http://biomedreports.com/2011041365978/neptune-technologies-and-bioresources-presents-significant-value-and-opportunity.html

Recs

0
Member Avatar KimLanners (< 20) Submitted: 4/21/2011 12:06:32 PM : Underperform Start Price: $3.50 NEPT Score: +100.38

damn what a crazy dog

Recs

0
Member Avatar manvsmonkey (79.36) Submitted: 6/14/2008 12:38:30 PM : Underperform Start Price: $2.50 NEPT Score: +80.32

The wolf pack has arrived

Recs

0
Member Avatar MrBuffetSentme (< 20) Submitted: 5/2/2008 10:59:25 PM : Outperform Start Price: $3.70 NEPT Score: -99.95

meds a big buss

Recs

1
Member Avatar tripleornothing (< 20) Submitted: 2/22/2008 10:59:16 AM : Outperform Start Price: $3.35 NEPT Score: -104.17

I expect the stock to be overall stagnant (yet fluctuating) for awhile, but to eventually have some nice growth once benefits are more widely known. Already studies support use for hyperlipidemia (lowers bad LDL cholesterol while raising good HDL cholesterol), ADHD, PMS, arthritis/aches/pains/inflammation (significantly reduces CRP markers), and skin health. This is despite some of the studies using tiny doses which are only 1/4th the amount that is in the product serving (which is two very small gelcaps or capliques).

Here are some supporting studies that I have bookmarked (there are more besides these actually) : http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17353582&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum , http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=15656713&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum , and http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=12777162&ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Doctor Mike give a good overall summary of it's pain relieving effects at http://www.proteinpower.com/drmike/uncategorized/why-krill-oil/

It has been shown to be significantly more effective than fish oil for controlling hyperlipidemia. The advantages over fish oil (or less advanced krill oils) being it's much better absorbing phospholipid form (rich in choline) and inherent high antioxidant capacity (over 300x greater than vitamin E for instance).

Yeah, right now people hear about krill oil and think "WTF? Must be some marketing garbage." Thus far there hasn't been much of a public promotion (besides press releases that only investors would read). Slowly though word is getting out and major health gurus such as Dr. Mercola, Dr. Weill (such as his featured article in Time Magazine), and Dr. Mike Eades have all recently endorsed krill oil and will likely snowball further exposure. The deal with Yoplait (yogurt) will be able to move foward now that NKO has been given GRAS status in the U.S.A (allowing it to be used in functional food). That would be a huge boon to recognition of NKO.

In summary I'd say this stock definitely has some long term potential (2 to 4 years), meaning the skeptics may want to wait and see if these recent developments (increased exposure) help out the companies thus far lagging finances. Personally I know the stuff works (helped with my mood and knee pains), so I'm no skeptic.

Recs

0
Member Avatar MJKpayday (99.77) Submitted: 1/20/2008 8:27:39 PM : Underperform Start Price: $3.15 NEPT Score: +108.24

I almost feel guilty underperforming this company, it's out of this world.

Recs

0
Member Avatar jericson (99.80) Submitted: 1/8/2008 4:52:48 PM : Underperform Start Price: $3.87 NEPT Score: +105.13

I don't know anything about this stock, except its symbol. It's hard to imagine a competent management would not notice the way it sounds. (Sound it out: N-ept.)

As a rule, shorting negative-cash-flow companies that issue a lot of stock and are researching technology that may never have a market even if it does pan out, tends to work out ok.

Recs

0
Member Avatar RationalAnarchy (84.74) Submitted: 10/2/2007 10:45:52 AM : Underperform Start Price: $4.90 NEPT Score: +101.27

Look at their financials.... is that a joke?

Not to mention it is a little faddy: krill?

Make more money off of selling them whole to food companies.

Recs

0
Member Avatar drkye (61.58) Submitted: 9/13/2007 3:12:27 PM : Underperform Start Price: $4.66 NEPT Score: +104.52

sounds like a fad to me

Results 1 - 20 of 20

Featured Broker Partners


Advertisement